Vuzix, supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced market expansion to support the NextAR surgical AR platform developed by Medacta. Having used the Vuzix Blade to complete the first smart glasses-based total knee replacement in the U.S. in 2020, Medacta recently received approval under the CE Mark for knee, shoulder and spine applications for its NextAR Augmented Reality Surgical Platform and FDA 510(k) clearance for shoulder application.
The NextAR platform employs a preoperative scan, with proprietary algorithms that create a personalized biomechanical model for each replacement. Surgeons equipped with Vuzix Blade Smart Glasses can then access biomechanical visualizations using augmented reality in real time, without having to divert their eyes from the procedure to glance at a computer screen. NextAR's smart delivery tools may improve efficiency in computer-assisted surgery by offering a compact solution that avoids the need for a bulky external detection platform. With a low upfront capital investment and overall lower cost per case compared to other technologies, this translates into greater efficiency in the operating room, which is particularly relevant for ASCs.
Source: Vusix Corporation